e-learning
resources
Stockholm 2002
Sunday 15.09.2002
Clinical aspects of antibiotic and nonantibiotic therapy of pneumonia in the ICU
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pharmacokinetics of instilled
versus
nebulized tobramycin or Imipenem in mechanically ventilated ICU patients
M. Adrover, J. R. Badia, D. Soy, M. Ferrer, A. Alarcón, N. Coromines, C. Codina, A. Torres (Barcelona, Spain)
Source:
Annual Congress 2002 - Clinical aspects of antibiotic and nonantibiotic therapy of pneumonia in the ICU
Session:
Clinical aspects of antibiotic and nonantibiotic therapy of pneumonia in the ICU
Session type:
Oral Presentation
Number:
232
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Adrover, J. R. Badia, D. Soy, M. Ferrer, A. Alarcón, N. Coromines, C. Codina, A. Torres (Barcelona, Spain). Pharmacokinetics of instilled
versus
nebulized tobramycin or Imipenem in mechanically ventilated ICU patients. Eur Respir J 2002; 20: Suppl. 38, 232
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Distribution of nebulised gentamicin in patients with bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004
Continuous infusion
versus
intermittent administration of ceftazidime in critically ill patients with pulmonary infections
Source: Eur Respir J 2006; 28: Suppl. 50, 275s
Year: 2006
Randomised controlled trial of sequential intravenous and oral azithromycin compared with intravenous ceftriaxone followed by cefixime both in combination with clarithromycin in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
Effectiveness of four early-rehabilitation techniques in sedated and ventilated patients in ICU
Source: International Congress 2018 – Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings
Year: 2018
In-vitro comparison of tobramycin nebulised using two different nebuliser systems
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010
Safety and pharmacokinetics of multiple-dose ciprofloxacin dry powder for inhalation in patients with moderate or severe COPD
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Changes in airway and tissue mechanics in ventilated COPD patients after nebulized bronchodilator agent
Source: Annual Congress 2007 - Advances in respiratory mechanics
Year: 2007
Clinical efficacy of bolus versus continuous-infusion of piperacillin-tazobactam in VAP treatment
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
A placebo-controlled study of liposomal amikacin for inhalation nebulized once daily in the treatment of bronchiectasis patients with chronic
pseudomonas aeruginosa
lung infection
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009
LATE-BREAKING ABSTRACT: Nebulized versus intravenous amikacin in ventilator-associated pneumonia Caused by pseudomonas aeruginosa
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Decannulation and NIV in tracheotomized and chronically ventilated patients
Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts
Year: 2012
Pharmacokinetics and antibacterial activity of inhaled liposomal ciprofloxacin hydrochloride in healthy volunteers and in cystic fibrosis (CF) patients
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009
Bronchoscopy in mechanically ventilated patients
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
The effect of nebulizer systems in inhaled tobramycin
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Clinical efficacy of arbekacin on MRSA pneumonia by intramuscularly injection
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Efficacy of inhaled dry powder tobramycin (TOBI Podhaler) in P. aeruginosa infected patients with bronchiectasis - iBEST study
Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy
Year: 2020
Long-term administration of aerosolised tobramycin in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 619s
Year: 2005
Sedation during flexible bronchoscopy in patients with respiratory failure: midazolam
vs.
midazolam plus alfentanil
Source: Annual Congress 2009 - Stents, needles and sedation
Year: 2009
Eradication treatment in Non CF bronchiectasis: The effect of inhaled antibiotics (tobramycin and colistin) on patients with pseudomonas aeruginosa
Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections
Year: 2017
No differences in early or late community-acquired pneumonia outcomes in patients treated with IV ceftriaxone plus oral clarithromycin extended-release tablets versus IV levofloxacin plus oral placebo
Source: Eur Respir J 2003; 22: Suppl. 45, 335s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept